Newsroom

 • June 15th 2010
TxCell announces the successfull completion of the Preclinical Development of TX-RAD in Inflammatory Arthritis
For more information, please click on flags  or     

 • April 29th 2010
TxCell announces Positive Preliminary Results
from the Phase I/IIa Clinical Trial of OvaSave in Crohn's Disease
For more information, please click on flags  or     

• January 25th 2010
TxCell appoints Miguel Forte as Chief Medical Officer
For more information, please click on flags     or     


• September 4th 2008
TxCell appoints Marc D. Beer as Chairman of the Supervisory Board
For more information, please click on flags     or 

• March 5th 2008
TxCell completes a 10.5 million second round and initiates its first clinical trial
For more information, please click on flags     or